Kirill A. Arsentiev

Kirill A. Arsentiev


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
VSValeriia Shtol
Valeriia Shtol
SKSophia Konovalova
Sophia Konovalova
KAKirill A. Arsentiev
Kirill A. Arsentiev
YTYulia I. Taranukha
Yulia I. Taranukha
PMPavel Musienko
Pavel Musienko
Biomaterials for neural tissue engineering, cell delivery, and chronic neural interfaces are conventionally characterized through physicochemical descriptors such as stiffness, topography, surface chemistry, and degradation rate. However, their biological effect is mediated by the material–tissue interface, a dynamic layer formed through protein adsorption, extracellular matrix ligand presentation, and progressive cellular remodeling, that determines how these design parameters are translated into neuronal and glial responses. This review synthesizes current evidence on how neurons, astrocytes, and microglia sense the material–tissue interface, how integrin-dependent adhesion complexes, mechanosensitive Piezo1 channels, and downstream FAK/Src, RhoA/ROCK, and YAP/TAZ pathways transduce interfacial cues into intracellular signaling, and how key design variables (mechanical properties, architecture, surface chemistry, electrical conductivity, and degradation) can be tuned to direct these processes in regenerative scaffolds and chronic neural interfaces. Particular attention is given to studies distinguishing direct neuronal effects from glia-mediated modulation, since concurrent changes in neuronal and glial markers are often reported without establishing causal neuron–glia interaction. We further discuss methodological limitations, including model mismatch across 2D, 3D, and in vivo systems and insufficient duration of chronic observation, that constrain current interpretations of biomaterial-induced neuron–glia crosstalk. We argue that functional biomaterial design for neural applications should move from optimizing isolated cellular readouts toward multicellular experimental frameworks capable of resolving neuron–glia–ECM interactions over physiologically relevant timescales.

5 November 2026 in Cells
Verified
Journal Article
Open access
PDF file
VSValeriia Shtol
Valeriia Shtol
SKSophia Konovalova
Sophia Konovalova
KAKirill A. Arsentiev
Kirill A. Arsentiev
YTYulia I. Taranukha
Yulia I. Taranukha
PMPavel Musienko
Pavel Musienko
Biomaterials for neural tissue engineering, cell delivery, and chronic neural interfaces are conventionally characterized through physicochemical descriptors such as stiffness, topography, surface chemistry, and degradation rate. However, their biological effects are mediated by the material–tissue interface, which evolves through protein adsorption, extracellular matrix ligand presentation, and progressive cellular remodeling and determines how these design parameters are translated into neuronal and glial responses. This review synthesizes current evidence on how neurons, astrocytes, and microglia sense the material–tissue interface, how integrin-dependent adhesion complexes, mechanosensitive Piezo1 channels, and downstream FAK/Src, RhoA/ROCK, and YAP/TAZ pathways transduce interfacial cues into intracellular signaling, and how key design variables (mechanical properties, architecture, surface chemistry, electrical conductivity, and degradation) can be tuned to direct these processes in regenerative scaffolds and chronic neural interfaces. Particular attention is given to studies distinguishing direct neuronal effects from glia-mediated modulation, since concurrent changes in neuronal and glial markers are often reported without establishing causal neuron–glia interaction. We further discuss methodological limitations that constrain current interpretations of biomaterial-induced neuron–glia crosstalk, including discrepancies between 2D, 3D, and in vivo models and insufficient durations of chronic observation. We argue that functional biomaterial design for neural applications should move from optimizing isolated cellular readouts toward multicellular experimental frameworks capable of resolving neuron–glia–ECM interactions over physiologically relevant timescales.